| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.049 | 0.7 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |